AMYLYX PHARMACEUTICALS INC has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets pharmaceuticals are GORDAGEN PHARMACEUTICALS PTY LTD, NEUROTEC PHARMA S L and HEDONIST BIOCHEMICAL TECHNOLOG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 | |
#9 | Hungary | 1 | |
#10 | Montenegro | 1 | |
#11 | Serbia | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Klee Justin | 21 |
#2 | Cohen Joshua B | 15 |
#3 | Cohen Joshua | 5 |
#4 | Joshua B Cohen | 2 |
#5 | Justin Klee | 2 |
#6 | Cohen Joshua B B | 1 |
Publication | Filing date | Title |
---|---|---|
US2014288030A1 | Compositions for improving cell viability and methods of use thereof |